Genmin Stock Quote GEN - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

0.027

Bid

0.025

Ask

0.028

Volume

192,131

0.026 Day's Range 0.027

0.022 52 Week Range 0.15

Market Cap

18.501M

Previous Close

0.027

Open

0.027

Last Trade

50000

0.027

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

991,812

Shares Outstanding

685,229,436

Dividend Yield

PE Ratio

-1.81

Earnings Per Share (EPS)

-0.02

Revenue

Net Profit

-11.38M

Sector

Metal Mining Services

Industry

Metal Mining Services

Website

genmingroup.com

Headquarters

Perth, Western Australia, Aus

Founded

Genmin Limited is listed in the Metal Mining Services sector of the Australian Stock Exchange with ticker GEN. The last closing price for Genmin was AUD0.03. Over the last year, Genmin shares have traded in a share price range of AUD 0.022 to AUD 0.15.

Genmin currently has 685,229,436 shares outstanding. The market capitalization of Genmin is AUD18.50 million. Genmin has a price to earnings ratio (PE ratio) of -1.81.

Genmab Files IND for HuMax-TF-ADC

Company Announcement IND for HuMax(R)-TF-ADC submitted to FDA Genmab's first IND submission for antibody-drug conjugate (ADC) product...

Genentech and Biogen Idec Refused a Re-hearing of U.S. Court of Appeals Decision in the Arzerra Patent Infringement Case

Company Announcement Genentech and Biogen Idec refused re-hearing in Arzerra patent infringement case COPENHAGEN, Denmark, July 15, 2013...

Genmab Collaborator GSK Starts New Ofatumumab Phase III Study in Rare Skin Disorder

Company Announcement First Phase III study with subcutaneous formulation of ofatumumab Ofatumumab to be investigated in new autoimmune...

Genmab and ADC Therapeutics Enter Co-Development Collaboration for an Antibody-Drug Conjugate Combining HuMax-TAC and PBD Warhe

Media Release Antibody-drug conjugate (ADC) to be developed for cancer Combines strength of HuMax(R)-TAC with next generation...

Teprotumumab Restarts Clinical Development in New Indication

Company Announcement Teprotumumab (RG1507) to be investigated for new indication River Vision Development Corporation to conduct...

Genmab Launches Sponsored Level 1 American Depositary Receipt (ADR) Program

Company Announcement Genmab establishes Sponsored Level 1 ADR program Genmab ADRs can be traded on US over-the-counter (OTC) market...

GSK and Genmab Announce Positive Top-Line Results From Pivotal Study of ARZERRA(R) (ofatumumab) Combined With Chlorambucil in P

Company Announcement Median 22.4 month progression free survival in patients treated with ofatumumab plus chlorambucil, an improvement of...

Genentech and Biogen Idec Have Filed for a Re-hearing of U.S. Court of Appeals Decision in the Arzerra Patent Infringement Case

Company Announcement Genentech and Biogen Idec have filed for re-hearing in the United States COPENHAGEN, Denmark, May 17, 2013 (GLOBE...

Genmab Announces Financial Results for the First Quarter of 2013

COPENHAGEN, Denmark, May 7, 2013 (GLOBE NEWSWIRE) -- Interim Report First Quarter 2013 Arzerra(r) received approval in Japan Arzerra net...

Genmab Announces Top-Line Phase II Results for Ofatumumab Combined With Bendamustine in Untreated and Relapsed Chronic Lymphocy

Company Announcement 95% overall response rate and 43% complete response rate in patients with previously untreated chronic lymphocytic...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.001	3.84615384615	0.026	0.03	0.025	919310	0.0279259	DE
4	0.001	3.84615384615	0.026	0.031	0.022	1077904	0.02604683	DE
12	-0.01	-27.027027027	0.037	0.049	0.022	991812	0.03149631	DE
26	-0.017	-38.6363636364	0.044	0.049	0.022	740933	0.03255905	DE
52	-0.123	-82	0.15	0.15	0.022	653744	0.04645375	DE
156	-0.163	-85.7894736842	0.19	0.28	0.022	489020	0.08662714	DE
260	-0.293	-91.5625	0.32	0.34	0.022	438519	0.13190409	DE

GEN - Frequently Asked Questions (FAQ)

What is the current Genmin share price?

The current share price of Genmin is AUD 0.027

How many Genmin shares are in issue?

Genmin has 685,229,436 shares in issue

What is the market cap of Genmin?

The market capitalisation of Genmin is AUD 18.5M

What is the 1 year trading range for Genmin share price?

Genmin has traded in the range of AUD 0.022 to AUD 0.15 during the past year

What is the PE ratio of Genmin?

The price to earnings ratio of Genmin is -1.81

What is the reporting currency for Genmin?

Genmin reports financial results in AUD

What is the latest annual profit for Genmin?

The latest annual profit of Genmin is AUD -11.38M

What is the registered address of Genmin?

The registered address for Genmin is LONDON HOUSE, SUITE 3 LEVEL 8, 216 ST GEORGES TERRACE, PERTH, WESTERN AUSTRALIA, 6000

What is the Genmin website address?

The website address for Genmin is genmingroup.com

Which industry sector does Genmin operate in?

Genmin operates in the METAL MINING SERVICES sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
OSLOncosil Medical Ltd	AUD 0.92 (30,566.67%)	10.07k
OSLOCOncoSil Medical Ltd	AUD 0.095 (9,400.00%)	9.94k
TALTalius Group Ltd	AUD 0.062 (675.00%)	50k
TM1OTerra Metals Ltd	AUD 0.018 (157.14%)	50k
HTMOHighTech Metals Ltd	AUD 0.02 (81.82%)	12.5k
JLLOJindalee Lithium Ltd	AUD 0.04 (-55.56%)	5k
VMLVital Metals Limited	AUD 0.002 (-33.33%)	6.78M
AXPAXP Energy Limited	AUD 0.001 (-33.33%)	50k
AOKAustralian Oil Company Ltd	AUD 0.002 (-33.33%)	15k
PIMOPinnacle Minerals Ltd	AUD 0.002 (-33.33%)	37.5k
OB1Orbminco Ltd	AUD 0.001 (0.00%)	106.9M
NMGNew Murchison Gold Ltd	AUD 0.019 (8.57%)	99.66M
DTRDateline resources Ltd	AUD 0.091 (-9.00%)	81.46M
VAUVault Minerals Ltd	AUD 0.44 (2.33%)	72.84M
RMLResolution Minerals Ltd	AUD 0.034 (0.00%)	69.05M